While the agenda for the health insurance registration of the ultra-high-priced innovative drug Kymriah and the expansion of immuno-cancer drug Keytruda benefits have been in full swing since the afternoon of today (13th), patient groups gathered in front of the Kukje Electronic Center's Smart Work Center.

Patient maximum co-payment of 1 million won

Of the patients' Union including patient maximum co-payment of 1 million won told the Drug Reimbursement Evaluation Committee, that the committee should pass the Kymriah insurance registration agenda and the expansion of Keytruda benefit standards, and presidential candidates insisted on the introduction of a "fast new drug health insura